Explorer les evidences

5,9 odds_ratioIndividuals living in conflict zones in Nigeria were nearly six times as likely to test positive for hepatitis C (adjusted odds ratio = 5.90).

Nigeriahépatite Cobservé 2018publié 2021Annals of global healthPubMeddocument de 12 observations

1,1 %The prevalence of HIV-hepatitis B-hepatitis C triple infection among people living with HIV/AIDS in a rural Northern Nigerian community was 1.1%.

Nigeriahépatite B · hépatite C · VIH/sidapublié 2020The Pan African medical journalPubMeddocument de 4 observations

120 522 patientsAs of December 2019, 120,522 patients initiated hepatitis C virus treatment.

Nigeriahépatite Cobservé December 2019publié 2020BMJ global healthPubMeddocument de 6 observations

13,3 %The overall prevalence of HCV infection among diabetic patients assayed was 13.3%.

Nigeriahépatite Cpublié 2020BMC infectious diseasesPubMeddocument de 7 observations

1,8 %HCV was detected in 1.8% of 400 blood donors at the Federal Medical Center in Azare.

Nigeriahépatite Cpublié 2025BMC infectious diseasesPubMeddocument de 5 observations

8,9 %Among diabetic subjects with a history of sharing sharp objects, HCV seropositivity was 8.9%.

Nigeriahépatite Cpublié 2020BMC infectious diseasesPubMeddocument de 7 observations

0,8 %Prevalence of Anti-HCV among liver diseases patients in Osun State was 0.8%.

Nigeriahépatite Cpublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 4 observations

29,2 %Among HIV-infected patients in Port Harcourt, the prevalence of HCV infection was 29.2% in the 31–35 age range.

Nigeriahépatite C · VIH/sidapublié 2021African health sciencesPubMeddocument de 4 observations

87 %Hepatitis C screening was performed in 27 out of 31 hospitals (87%).

Nigeriahépatite Cobservé 2014publié 2016International healtheurope_pmcdocument de 11 observations

0,4 %Among 265 livestock handlers in Ibadan, Nigeria, 1 (0.4%) was coinfected with HBV and HCV.

Nigeriahépatite B · hépatite Cobservé October 2016 to April 2017publié 2024African health sciencesPubMeddocument de 5 observations

0,64 %Among HIV-positive patients aged 31–40 years in the study, the prevalence of HIV/HBV/HCV triple infection was 0.64%.

Nigeriahépatite B · hépatite C · VIH/sidaobservé 2019publié 2020Journal of immunoassay & immunochemistryPubMeddocument de 9 observations

14,9 %Among diabetic subjects with tertiary education, HCV seropositivity was 14.9%.

Nigeriahépatite Cpublié 2020BMC infectious diseasesPubMeddocument de 7 observations

80 US$Commodity costs for hepatitis C virus treatment fell to as low as US$80 per-cure commodity package, including WHO-prequalified generic drugs (sofosbuvir + daclatasvir).

Nigeriahépatite Cpublié 2020BMJ global healthPubMeddocument de 6 observations

0,14 %Among 2775 pregnant women in Nigeria, the seroprevalence of HIV-HCV dual infection was 0.14%.

Nigeriahépatite C · VIH/sidapublié 2025Antiviral therapyPubMeddocument de 7 observations

11,3 %Among male diabetic subjects, HCV seropositivity was 11.3%.

Nigeriahépatite Cpublié 2020BMC infectious diseasesPubMeddocument de 7 observations

81 individualsAmong those tested for hepatitis C in the medical outreach in Durum community, Bauchi State, Nigeria, 81 (41%) had positive results.

Nigeriahépatite Cobservé 2023publié 2023West African journal of medicinePubMeddocument de 11 observations